Ranbaxy settles violation dispute

Wed, 21 December 2011

13:09

Ranbaxy Laboratories of India agreed to a settlement with the United States Food and Drug Administration and will make a $500 million provision in relation to a Justice Department investigation to resolve a dispute about plant violations. More on the NYT.

TOP STORIES

No peace talks as Iran exits Pak, Trump cancels envoys' trip

An Iranian delegation, led by Foreign Minister Abbas Araghchi, concluded high-level meetings in Islamabad, delivering an 'official list of demands' to Pakistani leaders for the US and Israel. This comes as President Trump cancelled his...

Sooryavanshi's ton in vain as SRH down Rajasthan Royals

Vaibhav Sooryavanshi's explosive century went in vain as Ishan Kishan and Abhishek Sharma smashed half-tons as Sunrisers Hyderabad beat Rajasthan Royals by 5 wickets.

'Kejriwal Needs To Learn From Modi'

'The entire party is centred around one man and that is Arvind Kejriwal.''Till the time you are in Kejriwal's good books you are powerful. The day you are not with him, you are no one in the party.'

BJP shares Kejriwal's 'Sheesh Mahal 2' pics; 'fake', says AAP

The BJP has launched accusations against Arvind Kejriwal, alleging lavish spending and corruption related to his new bungalow in Delhi's Lodhi Estate, sparking a political row.

Punjab Kings pull off record chase, beat DC by 6 wkts

Punjab Kings chase down 265 in a record-breaking run-fest against Delhi Capitals as KL Rahul smashes 152 and Shreyas Iyer seals historic win in IPL 2026.